HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Esophageal adenocarcinoma presenting as pseudo-achalasia in a patient with juvenile polyposis syndrome: an enemy out of the blue.

AuthorsCarlene Lihalakha Chun, Saul Eisenstat, Shane Dormady, Charles Lombard, George Triadafilopoulos
JournalDigestive diseases and sciences (Dig Dis Sci) Vol. 56 Issue 7 Pg. 1944-8 (Jul 2011) ISSN: 1573-2568 [Electronic] United States
PMID21267778 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antiemetics
  • Antineoplastic Agents
  • Proton Pump Inhibitors
  • Taxoids
  • Docetaxel
  • Epirubicin
  • Trastuzumab
  • Cisplatin
  • Fluorouracil
Topics
  • Adenocarcinoma (secondary, therapy)
  • Adult
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Antiemetics (therapeutic use)
  • Antineoplastic Agents (therapeutic use)
  • Antineoplastic Protocols
  • Cisplatin (therapeutic use)
  • Combined Modality Therapy
  • Docetaxel
  • Epirubicin (therapeutic use)
  • Esophageal Achalasia (pathology, therapy)
  • Esophageal Neoplasms (pathology, therapy)
  • Fatal Outcome
  • Fluorouracil (therapeutic use)
  • Humans
  • Intestinal Polyposis (congenital, pathology, therapy)
  • Liver Neoplasms (drug therapy, secondary)
  • Male
  • Neoplastic Syndromes, Hereditary
  • Peritoneal Neoplasms (drug therapy, secondary)
  • Proton Pump Inhibitors (therapeutic use)
  • Taxoids (therapeutic use)
  • Trastuzumab

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: